Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands

Joshua Brooks, PhD
Senior Director at Alnylam Pharmaceuticals
Speaker

Profile

Josh Brooks is a Senior Director in Process Sciences at Alnylam Pharmaceuticals, where he leads the Process Control and Innovation group. His team focuses on Stage 1 process validation and introducing new technologies into GMP manufacturing to enhance robustness and scalability. Josh received his Ph.D. in organic chemistry from the University of Rochester in 2012 under Alison Frontier, followed by postdoctoral training with Derek Tan at Memorial Sloan Kettering. He began his industry career in process chemistry at Ionis Pharmaceuticals before joining Alnylam in 2017.

Agenda Sessions

  • Part 1: siRELIS: A Convergent Enzymatic Ligation Strategy for siRNA Manufacturing; Part 2: Enzyme Development for Oligonucleotide Therapeutics Manufacturing

    10:45